Rare diseases
Investigational molecules
Locations
Back to Greece685 clinical trials in Thessaloniki, Greece across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients
GreeceMetronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection
GreecePumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
GreeceEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
GreeceJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
GreeceLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GreeceGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GreeceA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
GreeceA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
GreeceLong-Term Study of Imeroprubart in Adults With Graves' Disease
GreeceLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
GreeceA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, multiple myeloma, and advanced malignancies. Research includes innovative treatments for bladder cancer and gastrointestinal tumors.
Investigations emphasize improving survival outcomes and treatment efficacy.
Clinical trials addressing various autoimmune disorders including cutaneous lupus erythematosus, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new biologics and targeted therapies.
Research focuses on developing more effective treatments with improved safety profiles.
Comprehensive studies on Type 1 Diabetes and obesity, investigating novel therapeutic approaches. Trials examine treatments for weight management and glycemic control.
Research aims to improve patient outcomes through innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
